| 摘要 |
PROBLEM TO BE SOLVED: To provide drugs for improving cerebral dysfunctions due to amyloid beta protein, with less side effects and excellent safety, and not causing variability in blood pressure.SOLUTION: An agent for improving cerebral dysfunction caused by amyloid beta protein contains, as an active ingredient, a peptide comprising Met-Lys-Pro. In one embodiment of the agent, the cerebral dysfunction caused by amyloid beta protein is Alzheimer-type dementia. In another embodiment of the agent, the Alzheimer-type dementia is a symptom that develops in elderly people.SELECTED DRAWING: None |
